How should I manage photosensitivity caused by methotrexate (weekly disease-modifying antirheumatic drug)?

Management of Methotrexate-Induced Photosensitivity

Patients taking methotrexate must implement strict sun protection measures including complete sun avoidance during peak hours, sun-protective clothing, and broad-spectrum sunscreen, particularly in the week before and after methotrexate administration. 1

Understanding the Risk

Methotrexate causes rare but potentially severe photosensitivity reactions, including an idiosyncratic phenomenon called UV reactivation (also termed "sunburn recall"). This occurs when methotrexate is administered 2-5 days after UV exposure, causing severe erythema and sometimes blistering specifically in previously sun-exposed areas while sparing UV-protected skin 2. Importantly, this can occur even without visible sunburn or erythema—subclinical sun damage is sufficient to trigger the reaction 3.

The FDA drug label explicitly warns that "lesions of psoriasis may be aggravated by concomitant exposure to ultraviolet radiation" and that "radiation dermatitis and sunburn may be 'recalled' by the use of methotrexate" 1.

Specific Prevention Strategies

Three-Pronged Sun Protection Approach

1. Sun avoidance: Minimize outdoor activities, especially during peak UV hours (10 AM - 4 PM)
2. Sun-protective clothing: Long sleeves, wide-brimmed hats, UV-protective fabrics
3. Broad-spectrum sunscreen: Apply liberally and reapply every 2 hours when outdoors 3

Critical Timing Considerations

• Highest risk period: The week before methotrexate administration through several days after 3, 4
• If a patient presents with any degree of sunburn or recent significant UV exposure (within 2-4 days), delay methotrexate administration by 5-7 days 4
• This delay is crucial even if the sunburn appears mild or is resolving

When Photosensitivity Occurs

If a patient develops photosensitivity reaction:

1. Immediately discontinue methotrexate until the reaction resolves
2. Provide supportive care: topical corticosteroids, cool compresses, pain management as needed
3. Monitor for systemic toxicity, as severe reactions may be accompanied by methotrexate toxicity requiring leucovorin rescue 4
4. Consider checking methotrexate levels if severe reaction occurs
5. Counsel patient on absolute sun avoidance during recovery

Special Considerations with UV Therapy

While guidelines note that methotrexate combined with narrowband UVB phototherapy can enhance efficacy for psoriasis 5, this combination carries inherent photosensitivity risk. The British Association of Dermatologists specifically warns that "high and low doses of MTX can be associated rarely with MTX photoreactivation" 2.

If combining methotrexate with UVB therapy:

• Time methotrexate administration carefully (avoid the 2-5 day window after UV exposure when possible)
• Use the lowest effective UV doses
• Monitor closely for enhanced erythema or unexpected reactions
• Note: Methotrexate combined with PУВА has higher skin cancer risk; long-term photocarcinogenesis risk with UVB combination remains unknown 2

Patient Education Essentials

Explicitly counsel patients that:

• Photosensitivity can occur at any methotrexate dose (low or high) 2
• Even brief sun exposure without visible burn can trigger severe reactions days later
• Sun protection is mandatory year-round, not just in summer
• They should report any sunburn or significant UV exposure before their next methotrexate dose
• Reactions can be severe enough to cause second-degree burns requiring hospitalization 4

Common Pitfall to Avoid

The most critical error is administering methotrexate to a patient with recent UV exposure (within 2-5 days), even if no visible sunburn is present. Case reports demonstrate that subclinical sun damage is sufficient to trigger severe UV reactivation 3, 6. Always ask about recent sun exposure before each methotrexate dose and delay administration if significant exposure occurred.